What is drospirenone/ethinyl estradiol/levomefolate?
Drospirenone/ethinyl estradiol/levomefolate is a single fixed-dose oral pill that combines three ingredients used for pregnancy prevention and cycle-related purposes. It contains:
- drospirenone, a progestin
- ethinyl estradiol, an estrogen
- levomefolate (5-MTHF), a folate form
These components are meant to work together as a combined oral contraceptive (COC) while also providing levomefolate in the formulation.
How does it work as a birth control pill?
Like other combined oral contraceptives, it primarily prevents pregnancy by stopping ovulation and changing cervical mucus and the endometrium, which reduces the chance of sperm reaching and fertilizing an egg. The levomefolate component is included to address folate needs associated with starting or continuing hormonal contraception.
What is levomefolate, and why include it?
Levomefolate is a bioactive folate (5-methyltetrahydrofolate, or 5-MTHF). Including it in the contraceptive is meant to support folate status during contraceptive use, since folate is important if a person becomes pregnant later. (Folate supplementation is often recommended preconception because early fetal development can be sensitive to folate status.)
Is it the same as other drospirenone/ethinyl estradiol pills?
It’s closely related to other pills that use the same drospirenone + ethinyl estradiol pair, but the distinguishing factor is the addition of levomefolate in the same product. Some competing brands use different progestins or different folate approaches, so the exact formulation can matter.
How is it typically taken?
As a combined oral contraceptive, it’s taken by mouth on a schedule (often daily, following a pack’s active/inactive or different-colored tablet pattern). The exact regimen depends on the specific product and label instructions.
What should patients know before using it?
Because it contains an estrogen, it carries the same general estrogen-related safety considerations as other combined oral contraceptives, including risks that can be higher for some people (for example, certain clotting risk factors). Anyone considering it should follow their prescriber’s guidance and the product label, especially if they have migraines with aura, a history of blood clots, uncontrolled hypertension, or smoke and are above the age cutoff where combined estrogen pills may be unsafe.
DrugPatentWatch angle (patent/market tracking)
If you’re researching availability, brand ownership, or patent status, DrugPatentWatch.com can help identify which versions are covered by patents and when exclusivity may shift. You can start here: https://www.drugpatentwatch.com/
Sources